These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 9836378)
1. Biological insights from clinical trials with anti-TNF therapy. Feldmann M; Charles P; Taylor P; Maini RN Springer Semin Immunopathol; 1998; 20(1-2):211-28. PubMed ID: 9836378 [No Abstract] [Full Text] [Related]
2. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Feldmann M; Maini RN Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034 [TBL] [Abstract][Full Text] [Related]
4. [Value of anti-TNF-alpha molecules in inflammatory and infectious diseases]. Fautrel B; Cherin P Rev Med Interne; 2000 Oct; 21(10):872-88. PubMed ID: 11075396 [TBL] [Abstract][Full Text] [Related]
5. [Role of anti-TNF therapy in rheumatoid arthritis]. Meyer O Presse Med; 2000 Mar; 29(9):463-8. PubMed ID: 10745935 [TBL] [Abstract][Full Text] [Related]
6. National Meeting of the American College of Rheumatology. November 8-12, 1998, San Diego, California. Badii M Clin Invest Med; 1999 Apr; 22(2):63-4. PubMed ID: 10340106 [No Abstract] [Full Text] [Related]
7. Cytokines in rheumatoid arthritis: trials and tribulations. Carteron NL Mol Med Today; 2000 Aug; 6(8):315-23. PubMed ID: 10904249 [TBL] [Abstract][Full Text] [Related]
8. Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases. Feldman M; Taylor P; Paleolog E; Brennan FM; Maini RN Transplant Proc; 1998 Dec; 30(8):4126-7. PubMed ID: 9865320 [No Abstract] [Full Text] [Related]
9. [Cytokines and anti-cytokine therapy in rheumatoid arthritis]. Lorenz HM; Kalden JR Internist (Berl); 2001 Jan; 42(1):55-6, 59-63. PubMed ID: 11271621 [No Abstract] [Full Text] [Related]
10. [62nd Congress of the American College of Rheumatology, San Diego, 8-12 November 1998]. Cherin P Rev Med Interne; 1999 Apr; 20(4):311-7. PubMed ID: 10327473 [No Abstract] [Full Text] [Related]
11. [Recombinant proteins or monoclonal antibodies: comparative properties and interest in rheumatoid arthritis]. Sibilia J Med Sci (Paris); 2009 Dec; 25(12):1033-8. PubMed ID: 20035675 [TBL] [Abstract][Full Text] [Related]
13. TNF inhibitors: a new age in rheumatoid arthritis treatment. Anderson DL Am J Nurs; 2004 Feb; 104(2):60-8; quiz 68-9. PubMed ID: 14767382 [No Abstract] [Full Text] [Related]
14. TNF-alpha inhibition: the need for a tumor necrosis factor thermostat. O'Dell JR Mayo Clin Proc; 2001 Jun; 76(6):573-5. PubMed ID: 11393494 [No Abstract] [Full Text] [Related]
15. [Therapeutic efficacy and the adverse effects of newly developed biological agents for rheumatoid arthritis]. Kondo H Nihon Naika Gakkai Zasshi; 2004 Jan; 93(1):153-60. PubMed ID: 14968591 [No Abstract] [Full Text] [Related]
17. How many patients are eligible for anti-TNF therapy in the UK? Douglas K; Bowman SJ Rheumatology (Oxford); 2001 Dec; 40(12):1416. PubMed ID: 11752515 [No Abstract] [Full Text] [Related]
18. Treatment of rheumatoid arthritis by TNF-blocking agents. Graninger W; Smolen J Int Arch Allergy Immunol; 2002 Jan; 127(1):10-4. PubMed ID: 11893849 [TBL] [Abstract][Full Text] [Related]
19. [Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies]. González-Gay MA; Agudo M Med Clin (Barc); 2010 May; 134(15):684-5. PubMed ID: 20176386 [No Abstract] [Full Text] [Related]